Essay Sample: Critical Appraisal of Evidence-Based Guidelines for Atherosclerosis

The medical practitioners are the front line to providing sustainable solutions to the healthcare epidemics. Poised to establishing the societal care needs the healthcare providers embrace their prime position and expertise to develop evidence-based healthcare guidelines to provide a methodological routine to providing care. This follows the increased demand for quality healthcare services which has been on the rise with medical practitioners striving to meet the healthcare expectations of the society. Medical providers have embraced productive and advanced procedures to ensure a keep up with the care pace showcased by the demand for improved care. In this case, the Evidence-Based Guideline is a practice procedure adopted by the medical providers in a bid to improving the quality of care. The evidence-based guidelines are established from a series of research findings and appraised studies published in the peer-reviewed medical journals (Damschroder, 2009). Drawn from the source, National Heart, Lung, and Blood Institute through its medical experts developed an evidence-based guideline on Atherosclerosis.

Is your time best spent reading someone else’s essay? Get a 100% original essay FROM A CERTIFIED WRITER!

Order now

In 2010, Atherosclerosis and other cardiovascular diseases accounted for over 1M deaths amounting to over 41% of total deaths in the US. NIHBI outlines that over 23% of the economic costs were directed onto the cardiovascular treatments costing $424 billion (NHLBI, 2010). Following the adversity and severity of the case in the cardiovascular diseases, the medical practitioners under NIHBI explored the subject to meet the societal demands. I choose this guideline following the severity of illness and the implications the disease on the society; the paper explores this guidance on the contributions initiated to contribute to the prevention and treatment of cardiovascular diseases such as the Atherosclerosis.

The National Heart, Lung, and Blood Institute through its medical team experts were led by NHLBI Dr. Elizabeth Nabel, Dr. Daniels a laboratory consultant, Dr. Gidding a medical researcher, Dr. Gateman a member of the health advisory Board among other medical advisors. These developers come to a wide range of health bodies such as the. The experts panel integrate their views to develop comprehensive, evidence-based guidelines to address the risk factors attached to CVD (NHLBI, 2010). Their expertise was crucial to their engagement in the development process with more focus being placed on their experience and understanding of the cardiovascular diseases.

Being the core leader in the development NHLBI was tasked with the choice of the right fit panel members as a disciplinary action to ensuring the success of the development process. The Interdisciplinary team was led by NHLBI expert representatives such as Barbara Dennison from the New York Department of Health, Mathew Gillman from Harvard Pilgrim Health and Brian W McCrindle from the Hospital for Sick Children among other expert panelists representing the NHLBI panel representatives.

The development process was financed by the stakeholders engaged in the plan with NHLBI being the core fund source of the program. The risk factors relating to the disease, the studies also emphasized on the cost factor through its synopsis of the current and past state of the science of the evidence drawn from the demographics affected by the disease. These demographics range from the children to the adults from different social classes in need of the medical treatment to the Atherosclerosis. Being evidence-based strategy; this development strategy is wholly based on the previous research findings from over 1000 published studies. The extensive base gives the development process a strategy that it employs in meeting the core goals of the development process.

All the findings were integrated on different tables termed as the evidence tables' to showcase the trend establishment and the connective patterns that can be employed in coming up with sustainable guidelines. After reviewing the findings from the evidence tables and other scholarly reports established, the panel undertakes supportive actions that require a collective consensus proposals to develop substantive recommendations to guide the treatment of Atherosclerosis. The findings are presented in the form of a report which is used to setup the guidelines to act as a reference in medicine (NHLBI, 2010).

These studies use the risk factors such as the cost, social factors, biological and physical factors to come up with findings on the knowledge and treatment of the disease. Analysis of the risk factor enables linking and provision of evidence-based being to the proclaimed basis. It is also critical to integrate all the needed skills and instruments before study if the researcher seeks to attain accurate data and publish an accurate or close to accurate report (Brown, 2009). This showcases the efficiency of the development process in providing a spark of reference and methodological recommendation for treatment of Atherosclerosis.

These factors were collected both through observations and the published literature from the periods of the early years. Also, the evidence is graded using the Schema where the experts are required to grade the findings from grade A to D showcasing the relevance of the results as per the panel's consensus opinions (NHLBI, 2010). The findings allow the goal of the study that is to provide the recommendations that can be embraced by the medical providers in providing quality care to the Atherosclerosis patients. These recommendations also surpass and meet the medical procedures to ultimately supporting the care for Atherosclerosis.

References

Brown, S. J. (2009). Evidenced-based nursing: The research-practice connection. Norwich, VT: Jones & Bartlett.

Damschroder, A. (2009). Fostering implementation of health services research findings into practice. Atlanta: Jones & Pratt.

NHLBI. (2010). Retrieved from NHBL: www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines/summary#